Investors

Investors ▾

Press releases

September 30, 2020 - 08:27

Delisting

DOWNLOAD

September 21, 2020 - 19:33

Final results

DOWNLOAD

September 18, 2020 - 19:36

Provisional results sell-out

DOWNLOAD

Presentations

Company presentation FY2019 results update

DOWNLOAD

Company presentation_3Q and 9M 2019 update

DOWNLOAD

Investor events

October 2-4 2019

ARM Cell & Gene Meeting on the MESA

Subscribe to press releases

Contacts

Investor Relations & Communication Department
Telefono: +39 02 21277.321
E-mail: investor.relations@molmed.com

Investors

Dear Users, we would like to inform you that, as of 30 September, AGC Biologics S.p.A. (formerly MolMed S.p.A.) is no longer listed on the Milan Stock Exchange and has become part of the AGC Biologics Group. For any information on the company and the group, you are kindly invited to consult the websitewww.agcbio.com.
The contents present on this portal (www.molmed.com) are updated until the date of September 30, 2020 and will be available for the time frame foreseen by applicable regulations.
In addition, the "work with us" section is still active, while the contact details are no longer accessible.

Investors ▾

Press releases

Presentations

Investor events

Subscribe to press releases

About us

About us ▾

Pipeline

Pipeline ▾

GMP Solutions

GMP Solutions ▾

Investors

Investors ▾

Governance

Governance ▾

News & Events

News ▾